Telix Pharmaceuticals Limited
TLPPF
$16.05
-$0.1419-0.88%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 974.90% | 329.81% | 200.99% | 138.74% | 104.18% |
| Total Depreciation and Amortization | 18.34% | 20.33% | 20.82% | 27.21% | 19.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.07% | -22.17% | -49.98% | -48.69% | 23.95% |
| Change in Net Operating Assets | -94.04% | -187.14% | -3,140.78% | -3,140.78% | -3,140.78% |
| Cash from Operations | 79.06% | 174.07% | 412.43% | 179.43% | 134.54% |
| Capital Expenditure | -197.33% | -131.74% | -44.16% | -34.24% | -32.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1,131,777.78% | -6,336.86% | -2,592.53% | 100.28% | 100.28% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -382.69% | -599.34% | -132,577.84% | -354.31% | -59.77% |
| Cash from Investing | -433.71% | -501.75% | -681.80% | -139.35% | -39.86% |
| Total Debt Issued | 11,295.73% | 5,781.55% | 8.62% | 22.78% | 90.98% |
| Total Debt Repaid | -40.86% | -54.06% | -72.90% | -38.19% | -74.00% |
| Issuance of Common Stock | -84.98% | -52.17% | -4.20% | -93.42% | -96.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 27.71% | -- |
| Cash from Financing | 6,152.56% | 3,386.10% | -12.39% | -93.09% | -94.63% |
| Foreign Exchange rate Adjustments | 2,632.10% | 2,196.56% | -532.62% | -83.40% | -526.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7,953.83% | 3,387.42% | -237.27% | -97.06% | -92.93% |
